Investor Visium Asset Management, LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Visium Asset Management, LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2017-02-15 13G/A NRX / NephroGenex, Inc. 130,000 130,000
2017-02-15 13G/A CYNA / Cynapsus Therapeutics Inc. 750,000 0
2017-02-15 13G/A ENZY / Enzymotec Ltd. 2,200,000 0
2017-02-15 13G/A ENLV / Enlivex Therapeutics Ltd. 844,000 0
2017-02-15 13G/A ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) 1,370,000 0
2017-02-15 13G/A / Benefytt Technologies Inc 0
2017-02-15 13G/A LJPC / La Jolla Pharmaceutical Co. 1,182,013 0
2017-02-15 13G/A LPCN / Lipocine Inc. 977,768 0
2017-02-15 13G/A MED / Medifast, Inc. 0
2017-02-15 13G/A PCRX / Pacira BioSciences, Inc. 2,291,010 0
2017-02-15 13G/A ELOS / Syneron Medical Ltd. 0 0
2017-02-15 13G/A VCEL / Vericel Corporation 1,662,670 0
2017-02-15 13G/A US60877T1007 / Momenta Pharmaceuticals, Inc. 16,995 0
2017-02-15 13G/A SIEN / Sientra, Inc. 1,645,151 0
2017-02-15 13G/A ZLTQ / ZELTIQ Aesthetics, Inc. 2,448,867 0
2017-02-15 13G/A SAVA / Cassava Sciences, Inc. 0 0
2017-02-15 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 400,000 0
2017-02-15 13G/A 98235T107 / Wright Medical Group N.V. 276,503 0
2017-02-15 13G/A QTNT / Quotient Ltd 0 0
2017-02-15 13G/A SPNC / Spectranetics Corp. (The) 2,327,973 0
2017-02-15 13G/A ESPR / Esperion Therapeutics, Inc. 0 0
2017-02-15 13G/A SAGE / Sage Therapeutics, Inc. 1,893,009 0
2017-02-15 13G/A AMRI / Albany Molecular Research, Inc. 2,098,800 0
2017-02-15 13G/A NLTX / Neoleukin Therapeutics, Inc. 1,400,000 0
2017-02-15 13G/A ASMB / Assembly Biosciences, Inc. 1,699,999 0
2017-02-15 13G/A SIOX / Sio Gene Therapies Inc. 5,077,385 0
2017-02-15 13G/A AGTC / Applied Genetic Technologies Corp 475,000 0
2017-02-15 13G/A CBAY / CymaBay Therapeutics, Inc. 321,158 0
2017-02-15 13G/A CNMD / CONMED Corporation 1,807,015 0
2017-02-14 13G/A NRX / NephroGenex, Inc. 920,000 130,000
2017-02-14 13G/A 0
2016-07-21 13G/A QTNT / Quotient Ltd 2,028,149 0
2016-02-22 13G CYNA / Cynapsus Therapeutics Inc. 750,000
2016-02-12 13G/A AGTC / Applied Genetic Technologies Corp 475,000
2016-02-12 13G/A US60877T1007 / Momenta Pharmaceuticals, Inc. 3,000,000 16,995
2016-02-12 13G/A ELOS / Syneron Medical Ltd. 0
2016-02-12 13G/A NRX / NephroGenex, Inc. 920,000
2016-02-12 13G/A PCRX / Pacira BioSciences, Inc. 1,875,700 2,291,010
2016-02-12 13G/A NLTX / Neoleukin Therapeutics, Inc. 1,400,000 1,400,000
2016-02-12 13G/A ZLTQ / ZELTIQ Aesthetics, Inc. 2,168,705 2,448,867
2016-02-12 13G/A ASMB / Assembly Biosciences, Inc. 1,699,999
2016-02-12 13G/A ESPR / Esperion Therapeutics, Inc. 1,412,100 0
2016-02-12 13G/A 98235T107 / Wright Medical Group N.V. 276,503
2016-02-12 13G/A LPCN / Lipocine Inc. 977,768
2016-02-12 13G/A SIEN / Sientra, Inc. 1,645,151
2016-02-12 13G/A ENZY / Enzymotec Ltd. 2,200,000
2016-02-12 13G/A ENLV / Enlivex Therapeutics Ltd. 844,000
2016-02-12 13G/A QTNT / Quotient Ltd 2,028,149
2016-02-12 13G/A ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) 1,250,000 1,370,000
2016-02-12 13G/A SIOX / Sio Gene Therapies Inc. 5,080,000 5,077,385
2016-02-12 13G/A SPNC / Spectranetics Corp. (The) 2,231,000 2,327,973
2016-02-12 13G/A CNMD / CONMED Corporation 1,807,015
2016-02-12 13G/A VCEL / Vericel Corporation 1,662,670
2016-02-12 13G/A SAVA / Cassava Sciences, Inc. 0
2016-02-12 13G/A AMRI / Albany Molecular Research, Inc. 2,098,800
2016-02-12 13G/A VIRX / Viracta Therapeutics, Inc. 3,876,190 400,000
2016-02-12 13G/A CBAY / CymaBay Therapeutics, Inc. 321,158
2016-02-10 13G SAGE / Sage Therapeutics, Inc. 1,893,009
2016-02-08 13G LJPC / La Jolla Pharmaceutical Co. 1,182,013
2015-11-30 13G ZLTQ / ZELTIQ Aesthetics, Inc. 2,168,705
2015-10-22 13G/A SPNC / Spectranetics Corp. (The) 2,231,000
2015-09-21 13G NLTX / Neoleukin Therapeutics, Inc. 1,400,000
2015-08-31 13G ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) 1,250,000
2015-08-10 13G PCRX / Pacira BioSciences, Inc. 1,875,700
2015-06-22 13G SIOX / Sio Gene Therapies Inc. 5,080,000
2015-04-27 13G/A US60877T1007 / Momenta Pharmaceuticals, Inc. 3,000,000
2015-03-30 13G/A VIRX / Viracta Therapeutics, Inc. 3,876,190
2015-03-27 13G ESPR / Esperion Therapeutics, Inc. 1,412,100
2015-03-09 13G/A 98235T107 / Wright Medical Group N.V. 3,371,861
2015-02-13 13G/A ASMB / Assembly Biosciences, Inc. 834,284
2015-02-13 13G/A RVNC / Revance Therapeutics, Inc. 1,000,000
2015-02-13 13G/A ICPT / Intercept Pharmaceuticals Inc 0
2015-02-13 13G/A NVLN / NOVELION THERAPEUTICS INC. 6,200
2015-02-13 13G/A NRX / NephroGenex, Inc. 658,969
2015-02-13 13G/A VIRX / Viracta Therapeutics, Inc. 2,004,546
2015-02-13 13G/A SAVA / Cassava Sciences, Inc. 4,350,050
2015-02-13 13G/A VCEL / Vericel Corporation 1,630,731
2015-02-13 13G/A 76028H209 / Repros Therapeutics, Inc. 200
2015-02-13 13G/A UPI / Uroplasty Inc 0
2015-02-13 13G/A ZGNX / Zogenix Inc 0
2015-02-13 13G/A 98235T107 / Wright Medical Group N.V. 1,334,224
2015-02-13 13G/A US60877T1007 / Momenta Pharmaceuticals, Inc. 780,149
2015-02-13 13G/A NBSE / NeuBase Therapeutics, Inc. 1,033,772
2015-02-13 13G/A ENLV / Enlivex Therapeutics Ltd. 844,160
2015-02-12 13G/A AMRI / Albany Molecular Research, Inc. 3,200,000
2015-02-12 13G/A CNMD / CONMED Corporation 1,912,376
2015-02-12 13G/A MEIP / MEI Pharma, Inc. 1,021,099
2015-02-12 13G/A SLXP / Salix Therapeuticals, Inc. 3,078,972
2015-02-12 13G/A BKD / Brookdale Senior Living Inc. 4,240,255
2015-02-12 13G/A ELOS / Syneron Medical Ltd. 3,410,000
2015-02-12 13G/A LPCN / Lipocine Inc. 1,206,000
2015-02-12 13G/A 451731103 / Ignyta, Inc. 669,189
2015-02-12 13G/A SIEN / Sientra, Inc. 1,475,000
2015-02-12 13G/A / Benefytt Technologies Inc 495,000
2015-02-12 13G/A ENZY / Enzymotec Ltd. 2,125,000
2015-02-12 13G/A HZNP / Horizon Therapeutics Plc 4,497,065
2015-02-12 13G/A QTNT / Quotient Ltd 1,645,159
2015-02-12 13G/A SPNC / Spectranetics Corp. (The) 300
2015-02-12 13G/A US00163U1060 / AMAG Pharmaceuticals, Inc. 900
2015-01-30 13G AGTC / Applied Genetic Technologies Corp 1,000,000
2015-01-29 13G CBAY / CymaBay Therapeutics, Inc. 1,000,000
2014-12-12 13G VCEL / Vericel Corporation 1,422,475
2014-11-17 13G/A SLXP / Salix Therapeuticals, Inc. 3,388,336
2014-11-07 13G SIEN / Sientra, Inc. 1,475,000
2014-10-27 13G ZGNX / Zogenix Inc 7,500,000
2014-10-17 13G ENLV / Enlivex Therapeutics Ltd. 777,000
2014-10-02 13G 98235T107 / Wright Medical Group N.V. 3,058,160
2014-09-22 13G CNMD / CONMED Corporation 1,616,506
2014-09-11 13G 98235T107 / Wright Medical Group N.V. 2,427,219
2014-08-18 13G SLXP / Salix Therapeuticals, Inc. 3,090,290
2014-08-11 13G ENLV / Enlivex Therapeutics Ltd. 627,099
2014-08-07 13G HZNP / Horizon Therapeutics Plc 4,145,409
2014-07-24 13G SPNC / Spectranetics Corp. (The) 2,166,479
2014-07-11 13G NBSE / NeuBase Therapeutics, Inc. 1,225,000
2014-06-27 13G QTNT / Quotient Ltd 745,671
2014-04-21 13G BKD / Brookdale Senior Living Inc. 6,318,500
2014-03-10 13G ENZY / Enzymotec Ltd. 1,140,000
2014-03-05 13G US00163U1060 / AMAG Pharmaceuticals, Inc. 1,575,200
2014-02-24 13G RVNC / Revance Therapeutics, Inc. 1,083,606
2014-02-20 13G NRX / NephroGenex, Inc. 476,491
2014-02-20 13G 451731103 / Ignyta, Inc. 833,300
2014-02-14 13G/A ZGNX / Zogenix Inc 9,108,000
2014-02-14 13G/A SAVA / Cassava Sciences, Inc. 4,350,000
2014-02-14 13G/A ITMN / 1,482,072
2014-02-14 13G/A AFFY / Affymax, Inc. 0
2014-02-14 13G/A ACAD / ACADIA Pharmaceuticals Inc. 1,115,545
2014-02-14 13G/A US60877T1007 / Momenta Pharmaceuticals, Inc. 3,620,000
2014-02-14 13G/A VIRX / Viracta Therapeutics, Inc. 4,126,598
2014-02-14 13G/A AMRI / Albany Molecular Research, Inc. 3,150,000
2014-02-14 13G/A SNTS / Santarus, Inc 0
2014-02-14 13G/A ELOS / Syneron Medical Ltd. 3,405,000
2014-02-14 13G/A MEIP / MEI Pharma, Inc. 1,233,300
2014-02-14 13G/A ASMB / Assembly Biosciences, Inc. 1,800,000
2014-02-14 13G/A LPCN / Lipocine Inc. 1,206,000
2014-02-14 13G/A / Benefytt Technologies Inc 415,000
2014-02-14 13G/A NVLN / NOVELION THERAPEUTICS INC. 3,480,000
2014-02-14 13G/A UPI / Uroplasty Inc 1,079,400
2014-02-14 13G/A 76028H209 / Repros Therapeutics, Inc. 1,840,699
2014-02-14 13G/A MED / Medifast, Inc. 1,350,000
2014-01-10 13G ICPT / Intercept Pharmaceuticals Inc 1,026,129
2013-11-29 13G ZGNX / Zogenix Inc 8,927,753
2013-11-25 13G NVLN / NOVELION THERAPEUTICS INC. 3,481,688
2013-11-22 13G/A LPCN / Lipocine Inc. 1,206,000
2013-10-16 13G MEIP / MEI Pharma, Inc. 931,767
2013-08-23 13G AMRI / Albany Molecular Research, Inc. 1,600,600
2013-08-05 13G LPCN / Lipocine Inc. 1,206,000
2013-05-20 13G MED / Medifast, Inc. 938,165
2013-04-22 13G ITMN / 5,444,000
2013-04-12 13G SNTS / Santarus, Inc 3,834,704
2013-03-28 13G 76028H209 / Repros Therapeutics, Inc. 1,100,000
2013-03-25 13G/A OMPI / Obagi Medical Products, Inc. 95,500
2013-03-08 13G/A OMPI / Obagi Medical Products, Inc. 856,673
2013-02-19 13G / Benefytt Technologies Inc 250,000
2013-02-14 13G/A ACAD / ACADIA Pharmaceuticals Inc. 4,681,603
2013-02-14 13G/A VIRX / Viracta Therapeutics, Inc. 4,476,988
2013-02-14 13G/A AVDL / Avadel Pharmaceuticals plc 0
2013-02-14 13G/A ELOS / Syneron Medical Ltd. 2,686,000
2013-02-14 13G/A US60877T1007 / Momenta Pharmaceuticals, Inc. 4,000,000
2013-02-14 13G/A ANTH / Anthera Pharmaceuticals, Inc. 500,000
2013-02-14 13G/A RDEA / Ardea Biosciences, Inc. 0
2013-02-14 13G/A AFFY / Affymax, Inc. 2,075,000
2013-02-14 13G/A OMPI / Obagi Medical Products, Inc. 506,000
2013-02-14 13G/A SAVA / Cassava Sciences, Inc. 4,350,000
2013-02-14 13G/A ACER / Acer Therapeutics Inc 352,946
2013-02-14 13G/A PCRX / Pacira BioSciences, Inc. 1,600,000
2013-02-14 13G/A GRFS / Grifols, S.A. - Depositary Receipt (Common Stock) 3,143,239
2013-02-14 13G/A MRX / Marex Group plc 0
2013-02-14 13G/A UPI / Uroplasty Inc 1,079,400
2013-02-11 13G ASMB / Assembly Biosciences, Inc. 1,000,000
2013-02-07 13G WCRX / Warner Chilcott plc 10,251,086
2012-12-21 13G ACAD / ACADIA Pharmaceuticals Inc. 4,681,603
2012-12-20 13G US60877T1007 / Momenta Pharmaceuticals, Inc. 3,632,895
2012-09-21 13G VIRX / Viracta Therapeutics, Inc. 4,476,190
2012-04-20 13G PCRX / Pacira BioSciences, Inc. 1,890,234
2012-04-16 13G ELOS / Syneron Medical Ltd. 1,870,110
2012-04-05 13G AFFY / Affymax, Inc. 3,265,150
2012-02-23 13G/A OMPI / Obagi Medical Products, Inc. 963,972
2012-02-10 13G/A ELOS / Syneron Medical Ltd. 1,456,426
2012-02-10 13G/A ANTH / Anthera Pharmaceuticals, Inc. 2,403,583
2012-02-10 13G/A SQNM / Sequenom, Inc. 0
2012-02-10 13G/A AVDL / Avadel Pharmaceuticals plc 1,947,042
2012-02-10 13G/A ITMN / 1,457,553
2012-02-10 13G/A SAVA / Cassava Sciences, Inc. 4,425,000
2012-02-10 13G/A RDEA / Ardea Biosciences, Inc. 1,911,541
2012-02-10 13G/A ACER / Acer Therapeutics Inc 1,411,785
2012-02-10 13G/A MDVN / Medivation, Inc. 0
2012-02-10 13G/A NOVA / Sunnova Energy International Inc. 0
2012-02-10 13G/A US3723091043 / GenMark Diagnostics, Inc 0
2012-02-10 13G/A 0
2012-02-10 13G/A MRX / Marex Group plc 3,850,000
2012-02-10 13G/A HITK / Hi-Tech Pharmacal Co. 0
2012-02-10 13G/A NPSP / NPS Pharmaceuticals Inc 350,800
2012-02-10 13G/A UPI / Uroplasty Inc 1,079,400